Citigroup Inc Novavax Inc Put Options Transaction History

Citigroup Inc

  • $153 Billion
  • Q2 2024

Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$3.89 - $20.97 $3.62 Million - $19.5 Million
931,300 New
931,300 $11.8 Million
Q4 2023

Feb 09, 2024
SELL
$4.8 - $7.67 $4.05 Million - $6.47 Million
-843,600 Reduced 64.55%
463,200 $2.22 Million
Q3 2023

Nov 09, 2023
SELL
$6.81 - $9.74 $130,070 - $186,034
-19,100 Reduced 1.44%
1,306,800 $9.46 Million
Q2 2023

Aug 10, 2023
SELL
$6.67 - $9.52 $5.75 Million - $8.2 Million
-861,800 Reduced 39.39%
1,325,900 $9.85 Million
Q1 2023

May 11, 2023
BUY
$5.76 - $12.48 $5.93 Million - $12.9 Million
1,030,200 Added 89.0%
2,187,700 $15.2 Million
Q4 2022

Feb 09, 2023
BUY
$8.86 - $25.04 $1.75 Million - $4.94 Million
197,400 Added 20.56%
1,157,500 $11.9 Million
Q3 2022

Nov 10, 2022
BUY
$18.2 - $76.12 $10.7 Million - $44.9 Million
590,200 Added 159.56%
960,100 $17.5 Million
Q2 2022

Aug 10, 2022
SELL
$36.28 - $75.29 $43.6 Million - $90.4 Million
-1,201,200 Reduced 76.46%
369,900 $19 Million
Q1 2022

May 12, 2022
BUY
$69.73 - $142.9 $29.6 Million - $60.6 Million
424,000 Added 36.96%
1,571,100 $116 Million
Q4 2021

Feb 10, 2022
BUY
$134.56 - $217.97 $152 Million - $245 Million
1,126,300 Added 5414.9%
1,147,100 $164 Million
Q3 2021

Nov 10, 2021
BUY
$177.8 - $270.58 $3.7 Million - $5.63 Million
20,800 New
20,800 $4.31 Million

Others Institutions Holding NVAX

# of Institutions
284
Shares Held
84.8M
Call Options Held
5.43M
Put Options Held
9M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $731M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email